Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3245]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Gilteritinib improved survival for patients with acute myeloid leukaemia
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
11 Apr 2019
Inhibiting MDM2 to promote apoptosis in ALL
Prof Binghe Wang - Georgia State University, Atlanta, USA
Inhibiting MDM2 to promote apoptosis in ALL ( Prof Binghe Wang - Georgia State University, Atlanta, USA )
23 Jan 2019
Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia
Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA
Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia ( Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA )
19 Dec 2018
Bispecific CD19/22 CAR therapy in children and young adults with ALL
Dr Liora M Schultz - Stanford University, Palo Alto, USA
Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )
17 Dec 2018
Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent...
Dr Nicole Carreau - NYU Langone Health, New York, USA
Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent therapy ( Dr Nicole Carreau - NYU Langone Health, New York, USA )
17 Dec 2018
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone...
Dr Mark Bustoros - Harvard Medical School, Boston, USA
Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smouldering multiple myeloma ( Dr Mark Bustoros - Harvard Medical School, Boston, USA )
17 Dec 2018
Indoximod combined with chemotherapy in newly diagnosed AML patients
Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
Indoximod combined with chemotherapy in newly diagnosed AML patients ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )
17 Dec 2018
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Phase II trial of nivolumab combined with ibrutinib for patients with Richter...
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia
Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
17 Dec 2018
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed...
Dr Habte Yimer - Texas Oncology, Tyler, USA
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
17 Dec 2018
Blinatumomab as second salvage therapy in adults with relapsed/refractory...
Prof Alessandro Rambaldi - University of Milan, Milan, Italy
Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )
13 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation